X0708 D LIVE 0001832038 Invivyd, Inc. 1601 Trapelo Road Suite 178 Waltham MA MASSACHUSETTS 02451 (781) 819-0080 DELAWARE None Adagio Therapeutics, Inc. Corporation true 2020 David Hering 1601 Trapelo Road Suite 178 Waltham MA MASSACHUSETTS 02451 Executive Officer Director Chief Executive Officer and Director Fred Driscoll 1601 Trapelo Road Suite 178 Waltham MA MASSACHUSETTS 02451 Executive Officer Interim Chief Financial Officer Jill Andersen 1601 Trapelo Road Suite 178 Waltham MA MASSACHUSETTS 02451 Executive Officer Chief Legal Officer and Corporate Secretary Rebecca Dabora 1601 Trapelo Road Suite 178 Waltham MA MASSACHUSETTS 02451 Executive Officer Chief Technology and Manufacturing Officer Ellie Hershberger 1601 Trapelo Road Suite 178 Waltham MA MASSACHUSETTS 02451 Executive Officer Chief Development Officer Marc Elia 1601 Trapelo Road Suite 178 Waltham MA MASSACHUSETTS 02451 Director Director, Chair of the Board Tamsin Berry 1601 Trapelo Road Suite 178 Waltham MA MASSACHUSETTS 02451 Director Tom Heyman 1601 Trapelo Road Suite 178 Waltham MA MASSACHUSETTS 02451 Director Terry McGuire 1601 Trapelo Road Suite 178 Waltham MA MASSACHUSETTS 02451 Director Clive A. Meanwell 1601 Trapelo Road Suite 178 Waltham MA MASSACHUSETTS 02451 Director Christine Lindenboom 1601 Trapelo Road Suite 178 Waltham MA MASSACHUSETTS 02451 Director Michael S. Wyzga 1601 Trapelo Road Suite 178 Waltham MA MASSACHUSETTS 02451 Director Biotechnology Decline to Disclose 06b false 2022-11-15 false true true true false 0 23749998 23749998 0 See Form 8-K filed by Issuer on 11-17-22 for more details. The Issuer issued a warrant to purchase up to an aggregate of 6,824,712 common shares at an exercise price of $3.48 per share, which may vest in up to three separate tranches. false 1 0 0 0 false Invivyd, Inc. /s/ Jill Andersen Jill Andersen Chief Legal Officer and Corporate Secretary 2022-11-29